Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion type Assertion NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_head.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion wasGeneratedBy ECO_0000203 NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion wasDerivedFrom befree-20140225 NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion SIO_000772 23222563 NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion evidence source_evidence_literature NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.
- NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_assertion description "[Signalling pathways known to be disrupted in UM include: (1) the retinoblastoma pathway, probably as a result of cyclin D1 overexpression; p53 signalling, possibly as a consequence of MDM2 overexpression; and the P13K/AKT and mitogen-activated protein kinase/extracellular signal-related kinase pathway pathways that are disturbed as a result of PTEN and GNAQ/11 mutations, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203019.RAcYUtWWGUBn_647IwPANdMWOP7bIO4S8RyJtmCDmkhdU130_provenance.